Loading...
Augustinus Bader The Vitamin C Serum scores 8.7/9.8 and Paula's Choice Clinical Niacinamide 20% Treatment scores 8.7/9.8 — a near-tie where your skin type decides the winner.
These two are neck and neck — just 0.0 points apart.
Scores last verified: June 2026
24 unique
9 in common
14 unique
These two serums take different paths to a similar destination. Both formulas include solid hydrating ingredients, and the overall scores reflect that — the gap here is genuinely slim.
Augustinus Bader The Vitamin C Serum brings Ascorbyl Glucoside, Niacinamide, and Tocopheryl Acetate as actives, while paula's Choice Clinical Niacinamide 20% Treatment relies on Niacinamide, Acetyl Glucosamine, and Ascorbyl Glucoside. Both approaches have merit, but the positioning and supporting ingredients make the difference.
Augustinus Bader The Vitamin C Serum is better if you have
Paula's Choice Clinical Niacinamide 20% Treatment is better if you have
At luxury pricing with a score of 8.7, Augustinus Bader The Vitamin C Serum is a decent pick. Paula's Choice Clinical Niacinamide 20% Treatment sits at the mid-range level with a 8.7 score — the extra cost doesn't translate to better scores here.
It's a close call — both products score within 0.3 points of each other. Your choice depends on your specific skin concerns.
Based on ingredient analysis, Augustinus Bader The Vitamin C Serum scores higher overall. See the full score breakdown above for details on each attribute.
Yes, they share common ingredients. Check the ingredient face-off section above for a detailed comparison.
The key differences are in their active ingredients and formulation approach. Check the attribute battle above for a detailed breakdown.
Honest skincare intel. No jargon, no gatekeeping — just the ingredients decoded.
Some links on this site are affiliate links. We may earn a commission from purchases made through our links, at no extra cost to you. This helps us keep Gracie free and independent.
© 2026 Gracie. All rights reserved. Data sourced from Open Beauty Facts (ODbL) and EU CosIng.